ANEB
Anebulo Pharmaceuticals, Inc.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Total Trades
1
Buys
1
Sells
0
Largest Trade
$1M+
Insiders
1
Institutional Funds
12
Inst. Value
$1M+
Activist Filings
5
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| English Aron R. | Director | BUY | $1M+ | 10.1M | $0.99 | Dec 26, 2024 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 12 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| 22NW, LP | 15.5M | $1M+ | SH |
| Nantahala Capital Management, LLC | 3.0M | $1M+ | SH |
| MORGAN STANLEY | 399K | $100K–$500K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 127K | $100K–$500K | SH |
| RENAISSANCE TECHNOLOGIES LLC | 25K | $15K–$50K | SH |
| Ikarian Capital, LLC | 18K | $15K–$50K | SH |
| STATE STREET CORP | 13K | $1K–$15K | SH |
| VANGUARD GROUP INC | 10K | $1K–$15K | SH |
| UBS Group AG | 2K | $1K–$15K | SH |
| JPMORGAN CHASE & CO | 2K | $1K–$15K | SH |
| BlackRock, Inc. | 2K | $1K–$15K | SH |
| FNY Investment Advisers, LLC | 100 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Nantahala Capital Management, LLC
SC 13G/A · Feb 13, 2026
8.5%
3.5M shares
SC 13G · Mar 17, 2025
6.2%
2.5M shares
SC 13D/A · Feb 27, 2025
51.1%
21.9M shares
Nantahala Capital Management, LLC
SC 13G · Feb 14, 2025
8.6%
3.5M shares
SC 13D/A · Dec 27, 2024
51.1%
21.9M shares